CHI3L1 and rheumatoid arthritis: Serum CLIA assays demonstrated significantly elevated CHI3L1 levels in RA patients compared with healthy controls (P < 0.001), and ROC curve analysis indicated robust diagnostic performance (AUC = 0.907).